Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Early Surgery in Valvular Heart Disease

  • Kim, Dae-Hee (Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kang, Duk-Hyun (Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine)
  • Received : 2018.09.03
  • Accepted : 2018.09.27
  • Published : 2018.11.30
⟨ Previous Next ⟩

Abstract

The burden of valvular heart disease (VHD) is increasing with age, and the elderly patients with moderate or severe VHD are notably common. When to operate in asymptomatic patients with VHD remains controversial. The controversy is whether early surgical intervention should be preferred, or a watchful waiting approach should be followed. The beneficial effects of early surgery should be balanced against operative mortality and long-term results. Indications of early surgery in each of the VHD will be discussed in this review on the basis of the latest American and European guidelines.

Keywords

References

  1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 2006;368:1005-11. https://doi.org/10.1016/S0140-6736(06)69208-8
  2. Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol 2011;8:162-72. https://doi.org/10.1038/nrcardio.2010.202
  3. Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation 2018;137:e67-492.
  4. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 2005;352:875-83. https://doi.org/10.1056/NEJMoa041451
  5. Kang DH, Kim JH, Rim JH, et al. Comparison of early surgery versus conventional treatment in asymptomatic severe mitral regurgitation. Circulation 2009;119:797-804. https://doi.org/10.1161/CIRCULATIONAHA.108.802314
  6. Kang DH, Park SJ, Sun BJ, et al. Early surgery versus conventional treatment for asymptomatic severe mitral regurgitation: a propensity analysis. J Am Coll Cardiol 2014;63:2398-407. https://doi.org/10.1016/j.jacc.2014.02.577
  7. Suri RM, Vanoverschelde JL, Grigioni F, et al. Association between early surgical intervention vs watchful waiting and outcomes for mitral regurgitation due to flail mitral valve leaflets. JAMA 2013;310:609-16. https://doi.org/10.1001/jama.2013.8643
  8. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Thorac Cardiovasc Surg 2014;148:e1-132. https://doi.org/10.1016/j.jtcvs.2014.05.014
  9. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 2017;38:2739-91. https://doi.org/10.1093/eurheartj/ehx391
  10. Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol 2017;70:252-89. https://doi.org/10.1016/j.jacc.2017.03.011
  11. Le Tourneau T, Richardson M, Juthier F, et al. Echocardiography predictors and prognostic value of pulmonary artery systolic pressure in chronic organic mitral regurgitation. Heart 2010;96:1311-7. https://doi.org/10.1136/hrt.2009.186486
  12. La Canna G, Arendar I, Maisano F, et al. Real-time three-dimensional transesophageal echocardiography for assessment of mitral valve functional anatomy in patients with prolapse-related regurgitation. Am J Cardiol 2011;107:1365-74. https://doi.org/10.1016/j.amjcard.2010.12.048
  13. Ross J Jr, Braunwald E. Aortic stenosis. Circulation 1968;38 Suppl:61-7.
  14. Pellikka PA, Sarano ME, Nishimura RA, et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005;111:3290-5. https://doi.org/10.1161/CIRCULATIONAHA.104.495903
  15. Edwards FH, Peterson ED, Coombs LP, et al. Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol 2001;37:885-92. https://doi.org/10.1016/S0735-1097(00)01202-X
  16. Rosenhek R, Binder T, Porenta G, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000;343:611-7. https://doi.org/10.1056/NEJM200008313430903
  17. Pai RG, Kapoor N, Bansal RC, Varadarajan P. Malignant natural history of asymptomatic severe aortic stenosis: benefit of aortic valve replacement. Ann Thorac Surg 2006;82:2116-22. https://doi.org/10.1016/j.athoracsur.2006.07.043
  18. Kang DH, Park SJ, Rim JH, et al. Early surgery versus conventional treatment in asymptomatic very severe aortic stenosis. Circulation 2010;121:1502-9. https://doi.org/10.1161/CIRCULATIONAHA.109.909903
  19. Taniguchi T, Morimoto T, Shiomi H, et al. Initial surgical versus conservative strategies in patients with asymptomatic severe aortic stenosis. J Am Coll Cardiol 2015;66:2827-38. https://doi.org/10.1016/j.jacc.2015.10.001
  20. Genereux P, Stone GW, O'Gara PT, et al. Natural history, diagnostic approaches, and therapeutic strategies for patients with asymptomatic severe aortic stenosis. J Am Coll Cardiol 2016;67:2263-88.
  21. Pellikka PA, Nishimura RA, Bailey KR, Tajik AJ. The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis. J Am Coll Cardiol 1990;15:1012-7. https://doi.org/10.1016/0735-1097(90)90234-G
  22. Lim WY, Ramasamy A, Lloyd G, Bhattacharyya S. Meta-analysis of the impact of intervention versus symptom-driven management in asymptomatic severe aortic stenosis. Heart 2017;103:268-72. https://doi.org/10.1136/heartjnl-2016-309830
  23. The United States National Library of Medicine. Early surgery versus conventional treatment in very severe aortic stenosis [Internet]. Bethesda (MD): The United States National Library of Medicine; 2018 July [cited 2018 Oct 5]. Available from: https://ClinicalTrials.gov/show/NCT01161732.
  24. Banovic M, Iung B, Bartunek J, et al. Rationale and design of the Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): a randomized multicenter controlled event-driven trial. Am Heart J 2016;174:147-53. https://doi.org/10.1016/j.ahj.2016.02.001
  25. Bonow RO, Lakatos E, Maron BJ, Epstein SE. Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function. Circulation 1991;84:1625-35. https://doi.org/10.1161/01.CIR.84.4.1625
  26. de Meester C, Gerber BL, Vancraeynest D, et al. Early surgical intervention versus watchful waiting and outcomes for asymptomatic severe aortic regurgitation. J Thorac Cardiovasc Surg 2015;150:1100-8. https://doi.org/10.1016/j.jtcvs.2015.07.053
  27. Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the international collaboration on endocarditis-prospective cohort study. Arch Intern Med 2009;169:463-73. https://doi.org/10.1001/archinternmed.2008.603
  28. Kang DH. Timing of surgery in infective endocarditis. Heart 2015;101:1786-91. https://doi.org/10.1136/heartjnl-2015-307878
  29. Tornos P, Iung B, Permanyer-Miralda G, et al. Infective endocarditis in Europe: lessons from the Euro heart survey. Heart 2005;91:571-5. https://doi.org/10.1136/hrt.2003.032128
  30. Prendergast BD, Tornos P. Surgery for infective endocarditis: who and when? Circulation 2010;121:1141-52. https://doi.org/10.1161/CIRCULATIONAHA.108.773598
  31. Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015;36:3075-128. https://doi.org/10.1093/eurheartj/ehv319
  32. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998;17:2265-81. https://doi.org/10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B
  33. Vikram HR, Buenconsejo J, Hasbun R, Quagliarello VJ. Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: a propensity analysis. JAMA 2003;290:3207-14. https://doi.org/10.1001/jama.290.24.3207
  34. Kiefer T, Park L, Tribouilloy C, et al. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA 2011;306:2239-47.
  35. Lopez J, Sevilla T, Vilacosta I, et al. Prognostic role of persistent positive blood cultures after initiation of antibiotic therapy in left-sided infective endocarditis. Eur Heart J 2013;34:1749-54. https://doi.org/10.1093/eurheartj/ehs379
  36. Leung DY, Cranney GB, Hopkins AP, Walsh WF. Role of transoesophageal echocardiography in the diagnosis and management of aortic root abscess. Br Heart J 1994;72:175-81. https://doi.org/10.1136/hrt.72.2.175
  37. Anguera I, Miro JM, Vilacosta I, et al. Aorto-cavitary fistulous tract formation in infective endocarditis: clinical and echocardiographic features of 76 cases and risk factors for mortality. Eur Heart J 2005;26:288-97. https://doi.org/10.1093/eurheartj/ehi034
  38. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med 2001;345:1318-30. https://doi.org/10.1056/NEJMra010082
  39. Dickerman SA, Abrutyn E, Barsic B, et al. The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS). Am Heart J 2007;154:1086-94. https://doi.org/10.1016/j.ahj.2007.07.023
  40. Garcia-Cabrera E, Fernandez-Hidalgo N, Almirante B, et al. Neurological complications of infective endocarditis: risk factors, outcome, and impact of cardiac surgery: a multicenter observational study. Circulation 2013;127:2272-84. https://doi.org/10.1161/CIRCULATIONAHA.112.000813
  41. Delahaye F. Is early surgery beneficial in infective endocarditis? a systematic review. Arch Cardiovasc Dis 2011;104:35-44. https://doi.org/10.1016/j.acvd.2010.11.003
  42. Kim DH, Kang DH, Lee MZ, et al. Impact of early surgery on embolic events in patients with infective endocarditis. Circulation 2010;122 Suppl:S17-22. https://doi.org/10.1161/CIRCULATIONAHA.109.927665
  43. Kang DH, Kim YJ, Kim SH, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med 2012;366:2466-73. https://doi.org/10.1056/NEJMoa1112843
  44. Kang DH, Lee S, Kim YJ, et al. Long-term results of early surgery versus conventional treatment for infective endocarditis trial. Korean Circ J 2016;46:846-50. https://doi.org/10.4070/kcj.2016.46.6.846
  45. King RM, Schaff HV, Danielson GK, et al. Surgery for tricuspid regurgitation late after mitral valve replacement. Circulation 1984;70:I193-7.
  46. Staab ME, Nishimura RA, Dearani JA. Isolated tricuspid valve surgery for severe tricuspid regurgitation following prior left heart valve surgery: analysis of outcome in 34 patients. J Heart Valve Dis 1999;8:567-74.

Cited by

  1. The role of Cor‐Knot in the future of cardiac surgery: A systematic review vol.35, pp.11, 2018, https://doi.org/10.1111/jocs.14953
  2. Epidemiology of Heart Valve Disease in Taiwan : A Population-Based Cohort Study vol.62, pp.5, 2018, https://doi.org/10.1536/ihj.21-044
  3. A Risk Prediction Model for Operative Mortality after Heart Valve Surgery in a Korean Cohort vol.54, pp.2, 2021, https://doi.org/10.5090/jcs.20.102